Bo Nilsson

6.2k total citations
161 papers, 4.6k citations indexed

About

Bo Nilsson is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Bo Nilsson has authored 161 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 23 papers in Molecular Biology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Bo Nilsson's work include Cutaneous Melanoma Detection and Management (13 papers), Ovarian cancer diagnosis and treatment (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Bo Nilsson is often cited by papers focused on Cutaneous Melanoma Detection and Management (13 papers), Ovarian cancer diagnosis and treatment (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Bo Nilsson collaborates with scholars based in Sweden, United States and Finland. Bo Nilsson's co-authors include Ulrik Ringborg, Boel Ragnarsson-Olding, K. Sjövall, Nina Einhorn, Rolf Lewensohn, Stefan Seregard, Louise Bergman, Anna Sofia Lundgren, G. E. F. Lundell and Håkan Mellstedt and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Bo Nilsson

157 papers receiving 4.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bo Nilsson 1.6k 1.1k 687 679 583 161 4.6k
David B. Thomas 2.4k 1.5× 1.8k 1.6× 940 1.4× 572 0.8× 947 1.6× 222 9.1k
Rebecca Slack 1.5k 1.0× 1.0k 0.9× 846 1.2× 590 0.9× 642 1.1× 101 3.8k
K. Höffken 2.6k 1.7× 1.1k 1.0× 848 1.2× 788 1.2× 425 0.7× 186 5.4k
Anthony Robbins 2.3k 1.5× 1.3k 1.1× 1.3k 2.0× 234 0.3× 711 1.2× 112 6.7k
Annette Hasenburg 2.3k 1.5× 886 0.8× 718 1.0× 388 0.6× 902 1.5× 260 4.9k
Sareh Parangi 1.4k 0.9× 2.0k 1.8× 581 0.8× 332 0.5× 1.3k 2.2× 130 5.5k
Peter Kaatsch 1.6k 1.0× 1.1k 1.0× 1.1k 1.6× 185 0.3× 851 1.5× 162 8.0k
Caroline Mollévi 2.2k 1.4× 1.5k 1.4× 924 1.3× 418 0.6× 631 1.1× 137 4.8k
Christoph Rochlitz 3.6k 2.3× 2.1k 1.9× 800 1.2× 911 1.3× 399 0.7× 137 6.5k
Peter Mallmann 807 0.5× 706 0.6× 328 0.5× 704 1.0× 809 1.4× 278 4.7k

Countries citing papers authored by Bo Nilsson

Since Specialization
Citations

This map shows the geographic impact of Bo Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Nilsson more than expected).

Fields of papers citing papers by Bo Nilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Nilsson. The network helps show where Bo Nilsson may publish in the future.

Co-authorship network of co-authors of Bo Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Nilsson. A scholar is included among the top collaborators of Bo Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Nilsson. Bo Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carbin, Maria, et al.. (2023). Restoring trust? Public communication from Swedish Universities about the post-truth crisis. Critical Studies in Education. 64(5). 497–514. 2 indexed citations
2.
Nilsson, Bo, Kerstin Edin, John Kinsman, Kathleen Kahn, & Shane A. Norris. (2020). Obstacles to intergenerational communication in caregivers’ narratives regarding young people’s sexual and reproductive health and lifestyle in rural South Africa. BMC Public Health. 20(1). 791–791. 11 indexed citations
3.
Nilsson, Bo & Anna Sofia Lundgren. (2020). The #MeToo Movement: Men and Masculinity in Swedish News Media. The Journal of Men s Studies. 29(1). 8–25. 12 indexed citations
4.
Nilsson, Bo & Anna Sofia Lundgren. (2018). Morality of Discontent: The Constitution of Political Establishment in the Swedish Rural Press. Sociologia Ruralis. 59(2). 314–328. 8 indexed citations
5.
Hansson, Johan, Steinar Aamdal, Lars Bastholt, et al.. (2011). Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial. The Lancet Oncology. 12(2). 144–152. 66 indexed citations
6.
Ragnarsson-Olding, Boel, Per J. Nilsson, Lars B. Olding, & Bo Nilsson. (2008). Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years. Acta Oncologica. 48(1). 125–131. 52 indexed citations
7.
Bergman, Louise, et al.. (2008). Incidence of Conjunctival Melanoma in Sweden From 1960 to 2005. Investigative Ophthalmology & Visual Science. 49(13). 5699–5699. 1 indexed citations
8.
Mozaffari, Fariba, C. Lindemalm, Aniruddha Choudhury, et al.. (2008). Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study. Cancer Immunology Immunotherapy. 58(1). 111–120. 26 indexed citations
9.
Bergman, Louise, Anders Kvanta, Björn Steén, et al.. (2007). Preoperative Sub–Tenon’s Capsule Injection of Ropivacaine in Conjunction with General Anesthesia in Retinal Detachment Surgery. Ophthalmology. 114(11). 2055–2060. 13 indexed citations
10.
Bäcklund, L. Magnus, et al.. (2005). Mutations in Rb1 pathway-related genes are associated with poor prognosis in Anaplastic Astrocytomas. British Journal of Cancer. 93(1). 124–130. 25 indexed citations
11.
Ragnarsson-Olding, Boel, Bo Nilsson, Lena Kanter‐Lewensohn, B. Lagerlöf, & Ulrik Ringborg. (1999). Malignant melanoma of the vulva in a nationwide, 25‐year study of 219 Swedish females. Cancer. 86(7). 1285–1293. 1 indexed citations
12.
Einhorn, Nina, Marie Lundell, Bo Nilsson, Boel Ragnarsson-Olding, & K. Sjövall. (1999). Is there place for radiotherapy in the treatment of advanced ovarian cancer?. Radiotherapy and Oncology. 53(3). 213–218. 17 indexed citations
13.
Lönn, Ulf, Sigrid Lönn, Bo Nilsson, & Björn Stenkvist. (1996). Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis. Breast Cancer Research and Treatment. 39(2). 213–220. 10 indexed citations
14.
Auer, Gert, Nina Einhorn, Bo Nilsson, Claes Silfverswärd, & K. Sjövall. (1996). Biological Malignancy Grading in Early-Stage Ovarian Carcinoma. Acta Oncologica. 35(sup8). 93–98. 14 indexed citations
15.
Lönn, Ulf, Sigrid Lönn, Bo Nilsson, & Björn Stenkvist. (1994). Intratumoral heterogeneity for amplified genes in human breast carcinoma. International Journal of Cancer. 58(1). 40–45. 23 indexed citations
16.
Forsslund, Gun, Andris Kreicbergs, Bo Nilsson, & A. Zetterberg. (1992). Photographic densitometry for quantitative DNA analysis of cytologic and histologic specimens.. PubMed. 14(2). 153–60. 5 indexed citations
17.
18.
Morfeldt-Månson, Linda, Blenda Böttiger, Bo Nilsson, & Lars‐Victor von Stedingk. (1991). Clinical signs and laboratory markers in predicting progression to AIDS in HIV–1 infected patients. Scandinavian Journal of Infectious Diseases. 23(4). 443–449. 37 indexed citations
19.
Widström, Eeva, et al.. (1988). Analysis of patients utilizing emergency dental care in two Finnish cities. Acta Odontologica Scandinavica. 46(2). 105–112. 13 indexed citations
20.
Lindemalm, C., H Mellstedt, Bo Nilsson, et al.. (1987). Blood clonal B cell excess (CBE) at diagnosis in patients with non-Hodgkin lymphoma (NHL). Relation to clinical stage, histopathology and response to treatment. European Journal of Cancer and Clinical Oncology. 23(6). 749–753. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David B. Thomas Breakdown of academic impact, for papers by Rebecca Slack Breakdown of academic impact, for papers by K. Höffken Breakdown of academic impact, for papers by Anthony Robbins Breakdown of academic impact, for papers by Annette Hasenburg Breakdown of academic impact, for papers by Sareh Parangi Breakdown of academic impact, for papers by Peter Kaatsch Breakdown of academic impact, for papers by Caroline Mollévi Breakdown of academic impact, for papers by Christoph Rochlitz Breakdown of academic impact, for papers by Peter Mallmann
Rankless by CCL
2026